211 filings
Page 9 of 11
8-K
2kqt l0v1gceos4
29 Jun 18
Submission of Matters to a Vote of Security Holders
4:01pm
DEFA14A
cxpsew8m9w1n89 c5qv
11 Jun 18
Additional proxy soliciting materials
4:55pm
8-K
rlhqi75
14 May 18
Mersana Therapeutics Announces First Quarter 2018 Financial Results and Provides Business Updates
4:08pm
DEF 14A
nxtunb22
30 Apr 18
Definitive proxy
4:04pm
8-K
6yc0fx4 79sa
10 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
2fspx0jx7he3d
28 Mar 18
Mersana Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Business Updates
12:00am
10-K
owzt5j5g88d4rz
28 Mar 18
Annual report
12:00am
8-K
5u07l0kuy wssvh4
19 Mar 18
Departure of Directors or Certain Officers
12:00am
8-K
c9dlvj rgkx
12 Mar 18
Mersana Appoints David A. Spellman as Chief Financial Officer
12:00am
8-K
rmzjrzo3gke0sz1rdh4
2 Mar 18
Departure of Directors or Certain Officers
12:00am
S-8
uiquao083nnxurgy
2 Feb 18
Registration of securities for employees
12:00am
8-K
ok9eu0m9u9b
9 Nov 17
Mersana Announces Third Quarter 2017 Financial Results and Provides Business Updates
12:00am
8-K
ya8 n4lb1fgj4680o
6 Sep 17
Mersana Appoints Lawrence M. Alleva to Board of Directors
12:00am
8-K
b1q4f8cjq0p o8w4a3
11 Aug 17
Mersana Announces Second Quarter 2017 Financial Results and Provides Business Updates
12:00am
10-Q
u4w89qjoyks n91mw
11 Aug 17
Quarterly report
12:00am
S-8
9p8pe8j0l27
21 Jul 17
Registration of securities for employees
12:00am
8-K
18gvbpdqevlv
10 Jul 17
Amendments to Articles of Incorporation or Bylaws
12:00am
CT ORDER
qwc0dw c3k
29 Jun 17
Confidential treatment order
12:00am